Gene · 8215
Papers1,958
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,958
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of E3 ubiquitin ligases in bone homeostasis and related diseases. | Acta Pharm Sin B | 2023 | 37799379 | PubTator, text mining | PubMed |
| Research progress on the role of the Wnt signaling pathway in pituitary adenoma. | Front Endocrinol (Lausanne) | 2023 | 37780610 | PubTator, text mining | PubMed |
| The Molecular Basis of Wnt/β-Catenin Signaling Pathways in Neurodegenerative Diseases. | Int J Cell Biol | 2023 | 37780577 | PubTator, text mining | PubMed |
| Modulating Wnt/β-Catenin Signaling Pathway on U251 and T98G Glioblastoma Cell Lines Using a Combination of Paclitaxel and Temozolomide, A Molecular Docking Simulations and Gene Expression Study. | Chem Pharm Bull (Tokyo) | 2023 | 37779078 | PubTator, text mining | PubMed |
| Yin Yang 1 promotes the neuroendocrine differentiation of prostate cancer cells via the non-canonical WNT pathway (FYN/STAT3). | Clin Transl Med | 2023 | 37771187 | PubTator, text mining | PubMed |
| Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2. | Viruses | 2023 | 37766292 | PubTator, text mining | PubMed |
| Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor Progression. | Int J Mol Sci | 2023 | 37762212 | PubTator, text mining | PubMed |
| Interaction of the AKT and β-catenin signalling pathways and the influence of photobiomodulation on cellular signalling proteins in diabetic wound healing. | J Biomed Sci | 2023 | 37735655 | PubTator, text mining | PubMed |
| Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells. | Open Life Sci | 2023 | 37724115 | PubTator, text mining | PubMed |
| The known, unknown, and unknown unknowns of cell-cell communication in planarian regeneration. | Zool Res | 2023 | 37721107 | PubTator, text mining | PubMed |
| Signaling pathways in macrophages: molecular mechanisms and therapeutic targets. | MedComm (2020) | 2023 | 37706196 | PubTator, text mining | PubMed |
| Rho family small GTPase Rif regulates Wnt5a-Ror1-Dvl2 signaling and promotes lung adenocarcinoma progression. | J Biol Chem | 2023 | 37703992 | PubTator, text mining | PubMed |
| Wnt signaling pathway inhibitor promotes mesenchymal stem cells differentiation into cardiac progenitor cells in vitro and improves cardiomyopathy in vivo. | World J Stem Cells | 2023 | 37700819 | PubTator, text mining | PubMed |
| Dishevelled: An emerging therapeutic oncogene in human cancers. | Pathol Res Pract | 2023 | 37683388 | PubTator, text mining | PubMed |
| Treatment of multiple traumatized adolescents by enhancing regulation skills and reducing trauma related symptoms: rationale, study design, and methods of randomized controlled trial (the Mars-study). | BMC Psychiatry | 2023 | 37667200 | PubTator, text mining | PubMed |
| β-catenin inhibitors in cancer therapeutics: intricacies and way forward. | Bioengineered | 2023 | 37655825 | PubTator, text mining | PubMed |
| Research progress in the mechanism and treatment of osteosarcoma. | Chin Med J (Engl) | 2023 | 37649421 | PubTator, text mining | PubMed |
| RNF43 and ZNRF3 in Wnt Signaling - A Master Regulator at the Membrane. | Int J Stem Cells | 2023 | 37643759 | PubTator, text mining | PubMed |
| Immune regulation in gastric adenocarcinoma is linked with therapeutic efficacy and improved recovery. | Front Genet | 2023 | 37636266 | PubTator, text mining | PubMed |
| Effects of Hyperbaric Oxygen Intervention on the Degenerated Intervertebral Disc: From Molecular Mechanisms to Animal Models. | Cells | 2023 | 37626921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8215/papers?page=7